Cargando…
Peripheral artery disease in Germany (2009–2018): Prevalence, frequency of specialized ambulatory care and use of guideline-recommended therapy – A population-based study
BACKGROUND: Peripheral artery disease (PAD) patients have high morbidity and mortality rates, demonstrating a need for improved treatment strategies. While underuse and undertreatment have been reported, there is no clear picture of patterns in population-level disease prevalence, prescription of gu...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8454876/ https://www.ncbi.nlm.nih.gov/pubmed/34557822 http://dx.doi.org/10.1016/j.lanepe.2021.100113 |
_version_ | 1784570565895389184 |
---|---|
author | Rammos, Christos Steinmetz, Martin Lortz, Julia Mahabadi, Amir A. Petrikhovich, Olga Kirsch, Kristina Hering, Ramona Schulz, Mandy Rassaf, Tienush |
author_facet | Rammos, Christos Steinmetz, Martin Lortz, Julia Mahabadi, Amir A. Petrikhovich, Olga Kirsch, Kristina Hering, Ramona Schulz, Mandy Rassaf, Tienush |
author_sort | Rammos, Christos |
collection | PubMed |
description | BACKGROUND: Peripheral artery disease (PAD) patients have high morbidity and mortality rates, demonstrating a need for improved treatment strategies. While underuse and undertreatment have been reported, there is no clear picture of patterns in population-level disease prevalence, prescription of guideline-recommended pharmacotherapy, or frequency of contact with dedicated specialists. We present population-level data on changes in prevalence, care and treatment of PAD from 2009 to 2018 in Germany. METHODS: We analyzed the ambulatory claims data for all statutorily insured patients comprising 70.1 million patients each year and 87% of the German population. Prevalence was assessed by documentation of PAD and stratified by age and sex within the 10-year study timeframe. In addition, current ambulatory care, stratified by vascular specialists (vascular surgeons or angiologists), internists, cardiologists and primary care physicians, were examined. FINDINGS: Prevalence increased from 1·85% in 2009 to 3·14% in 2018, affecting 2·3 million patients in 2018 and more males (55%) than females (45%). A low level of visits to vascular specialists, with 11·1% receiving care from vascular surgeons and 8·1% from angiologists, was shown. Moreover, analysis of guideline-recommended prescriptions revealed increasing, but still insufficient, prescription frequencies among PAD patients between 2009 and 2016, from 42·6% to 56% for statins and from 40·2% to 48·0% for antiplatelets. INTERPRETATION: Our results show that the prevalence of PAD in Germany, as assessed by outpatient PAD documentation, is increasing and PAD patients are underutilizing specialized vascular care; moreover, the prescription frequency of guideline-recommended therapies remains low. There is a clear need to improve the referral and treatment algorithms in the high-risk PAD population. FUNDING: None. |
format | Online Article Text |
id | pubmed-8454876 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-84548762021-09-22 Peripheral artery disease in Germany (2009–2018): Prevalence, frequency of specialized ambulatory care and use of guideline-recommended therapy – A population-based study Rammos, Christos Steinmetz, Martin Lortz, Julia Mahabadi, Amir A. Petrikhovich, Olga Kirsch, Kristina Hering, Ramona Schulz, Mandy Rassaf, Tienush Lancet Reg Health Eur Research Paper BACKGROUND: Peripheral artery disease (PAD) patients have high morbidity and mortality rates, demonstrating a need for improved treatment strategies. While underuse and undertreatment have been reported, there is no clear picture of patterns in population-level disease prevalence, prescription of guideline-recommended pharmacotherapy, or frequency of contact with dedicated specialists. We present population-level data on changes in prevalence, care and treatment of PAD from 2009 to 2018 in Germany. METHODS: We analyzed the ambulatory claims data for all statutorily insured patients comprising 70.1 million patients each year and 87% of the German population. Prevalence was assessed by documentation of PAD and stratified by age and sex within the 10-year study timeframe. In addition, current ambulatory care, stratified by vascular specialists (vascular surgeons or angiologists), internists, cardiologists and primary care physicians, were examined. FINDINGS: Prevalence increased from 1·85% in 2009 to 3·14% in 2018, affecting 2·3 million patients in 2018 and more males (55%) than females (45%). A low level of visits to vascular specialists, with 11·1% receiving care from vascular surgeons and 8·1% from angiologists, was shown. Moreover, analysis of guideline-recommended prescriptions revealed increasing, but still insufficient, prescription frequencies among PAD patients between 2009 and 2016, from 42·6% to 56% for statins and from 40·2% to 48·0% for antiplatelets. INTERPRETATION: Our results show that the prevalence of PAD in Germany, as assessed by outpatient PAD documentation, is increasing and PAD patients are underutilizing specialized vascular care; moreover, the prescription frequency of guideline-recommended therapies remains low. There is a clear need to improve the referral and treatment algorithms in the high-risk PAD population. FUNDING: None. Elsevier 2021-05-03 /pmc/articles/PMC8454876/ /pubmed/34557822 http://dx.doi.org/10.1016/j.lanepe.2021.100113 Text en © 2021 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Research Paper Rammos, Christos Steinmetz, Martin Lortz, Julia Mahabadi, Amir A. Petrikhovich, Olga Kirsch, Kristina Hering, Ramona Schulz, Mandy Rassaf, Tienush Peripheral artery disease in Germany (2009–2018): Prevalence, frequency of specialized ambulatory care and use of guideline-recommended therapy – A population-based study |
title | Peripheral artery disease in Germany (2009–2018): Prevalence, frequency of specialized ambulatory care and use of guideline-recommended therapy – A population-based study |
title_full | Peripheral artery disease in Germany (2009–2018): Prevalence, frequency of specialized ambulatory care and use of guideline-recommended therapy – A population-based study |
title_fullStr | Peripheral artery disease in Germany (2009–2018): Prevalence, frequency of specialized ambulatory care and use of guideline-recommended therapy – A population-based study |
title_full_unstemmed | Peripheral artery disease in Germany (2009–2018): Prevalence, frequency of specialized ambulatory care and use of guideline-recommended therapy – A population-based study |
title_short | Peripheral artery disease in Germany (2009–2018): Prevalence, frequency of specialized ambulatory care and use of guideline-recommended therapy – A population-based study |
title_sort | peripheral artery disease in germany (2009–2018): prevalence, frequency of specialized ambulatory care and use of guideline-recommended therapy – a population-based study |
topic | Research Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8454876/ https://www.ncbi.nlm.nih.gov/pubmed/34557822 http://dx.doi.org/10.1016/j.lanepe.2021.100113 |
work_keys_str_mv | AT rammoschristos peripheralarterydiseaseingermany20092018prevalencefrequencyofspecializedambulatorycareanduseofguidelinerecommendedtherapyapopulationbasedstudy AT steinmetzmartin peripheralarterydiseaseingermany20092018prevalencefrequencyofspecializedambulatorycareanduseofguidelinerecommendedtherapyapopulationbasedstudy AT lortzjulia peripheralarterydiseaseingermany20092018prevalencefrequencyofspecializedambulatorycareanduseofguidelinerecommendedtherapyapopulationbasedstudy AT mahabadiamira peripheralarterydiseaseingermany20092018prevalencefrequencyofspecializedambulatorycareanduseofguidelinerecommendedtherapyapopulationbasedstudy AT petrikhovicholga peripheralarterydiseaseingermany20092018prevalencefrequencyofspecializedambulatorycareanduseofguidelinerecommendedtherapyapopulationbasedstudy AT kirschkristina peripheralarterydiseaseingermany20092018prevalencefrequencyofspecializedambulatorycareanduseofguidelinerecommendedtherapyapopulationbasedstudy AT heringramona peripheralarterydiseaseingermany20092018prevalencefrequencyofspecializedambulatorycareanduseofguidelinerecommendedtherapyapopulationbasedstudy AT schulzmandy peripheralarterydiseaseingermany20092018prevalencefrequencyofspecializedambulatorycareanduseofguidelinerecommendedtherapyapopulationbasedstudy AT rassaftienush peripheralarterydiseaseingermany20092018prevalencefrequencyofspecializedambulatorycareanduseofguidelinerecommendedtherapyapopulationbasedstudy |